Hoth Therapeutics, Inc. — Director's Dealing 2020

Apr 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2020-04-15

Reporting Person: Springer Graig (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-15	Common Stock	A	3333	—	Acquired	3333	Direct

Footnotes

F1: Issued for services rendered as a member of the Issuer's Board of Directors.

F2: The common stock was issued pursuant to the Issuer's 2018 Equity Incentive Plan and vests in 36 equal monthly installments with the first installment vesting on the date of grant.